Compare Abeona Therapeutics Inc (ABEO) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Eli Lilly And Co — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Eli Lilly And Co trades at $1,212.22 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 2564.2× Abeona Therapeutics Inc's market cap, and Eli Lilly And Co pays a 0.57% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | LLY | |
|---|---|---|
Market Cap | $421.19M | $1.08T |
Sector | Health | Health |
52-Week High | $7.45 | $1.24K |
52-Week Low | $4.17 | $639.43 |
Enterprise Value | $276.10M | $1.13T |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
